Skip to main content
Log in

Schmerztherapie bei Intensivpatienten

Pain therapy in intensive care patients

  • Leitthema
  • Published:
Der Anaesthesist Aims and scope Submit manuscript

Zusammenfassung

Schmerzen gehören zu den Erinnerungen an eine intensivmedizinische Behandlung, die Patienten am meisten belasten, und haben eine Reihe negativer physiologischer Konsequenzen. Mehr als die Hälfte aller Patienten berichten von mäßigen oder starken Schmerzen während ihrer Intensivbehandlung, insbesondere im Zusammenhang mit diagnostischen oder therapeutischen Prozeduren. Schmerzen und ihre funktionellen Konsequenzen bei Intensivpatienten sollten daher konsequent erfasst und behandelt werden. Im Mittelpunkt der pharmakologischen Schmerztherapie stehen Opioide wegen ihrer hohen analgetischen Potenz, nachteilig sind jedoch gastrointestinale Motilitätsstörungen und Toleranzentwicklungen. Bei Nichtopioiden ist die potenzielle Organtoxizität von nichtsteroidalen Antirheumatika (NSAR) bzw. Paracetamol zu beachten. Ketamin und α2-Agonisten können das analgetische Konzept ergänzen. In Analogie zur perioperativen Anwendung erscheint die i. v.-Gabe von Lidocain aufgrund eines reduzierten Opioidbedarfs und einer verbesserten gastrointestinalen Motilität auch in der Intensivmedizin vertretbar. Bei Regionalanalgesieverfahren sollte eine sorgfältige Abwägung zwischen ihrer oft guten Wirksamkeit und potenziellen Komplikationen durchgeführt werden. Nichtmedikamentöse Verfahren – insbesondere die transkutane elektrische Nervenstimulation (TENS) – haben sich in der postoperativen Schmerztherapie sehr bewährt. Auch wenn kaum Daten aus der Intensivmedizin vorliegen, erscheint ein Therapieversuch wegen ihrer geringen Komplikationsträchtigkeit gerechtfertigt.

Abstract

After intensive care unit (ICU) treatment, the recollection of experienced pain is one of the most burdensome aftermaths. In addition, pain has several negative physiological consequences. The majority of patients report moderate to severe pain while being treated on an ICU, often caused by diagnostic or therapeutic procedures. Pain and its functional consequences during ICU treatment should therefore be systematically recorded and treated. Due to their high analgesic potency, pharmacological pain therapy focuses on opioids; however, gastrointestinal motility disturbance and development of tolerance are disadvantages. When applying non-opioids, such as non-steroidal anti-inflammatory drugs (NSAID) and paracetamol, attention should be paid to their possible organ toxicity. Ketamine and α2-antagonists can complement the analgesic concept. Analogous to its perioperative administration, intravenous lidocaine in intensive care seems acceptable because of a favorable impact on opioid requirements and gastrointestinal motility. When using regional anesthesia the positive therapeutic effect and the possible complications need to be carefully weighed. Non-pharmaceutical procedures, especially transcutaneous electrical nerve stimulation (TENS), have proven successful in postoperative pain management. Even if only limited data from intensive care are available, a therapeutic attempt seems justifiable because of the low risk of complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Awissi DK, Begin C, Moisan J et al (2012) I‑SAVE study: impact of sedation, analgesia, and delirium protocols evaluated in the intensive care unit: an economic evaluation. Ann Pharmacother 46:21–28

    Article  PubMed  Google Scholar 

  2. Ballantyne JC, Sullivan MD (2015) Intensity of chronic pain—the wrong metric? N Engl J Med 373:2098–2099

    Article  PubMed  CAS  Google Scholar 

  3. Baumbach P, Gotz T, Gunther A et al (2016) Prevalence and characteristics of chronic intensive care-related pain: the role of severe sepsis and septic shock. Crit Care Med 44:1129–1137

    Article  PubMed  Google Scholar 

  4. Belgrade M, Hall S (2010) Dexmedetomidine infusion for the management of opioid-induced hyperalgesia. Pain Med 11:1819–1826

    Article  PubMed  Google Scholar 

  5. Bernards CM (2002) Understanding the physiology and pharmacology of epidural and intrathecal opioids. Best Pract Res Clin Anaesthesiol 16:489–505

    Article  PubMed  CAS  Google Scholar 

  6. Chanques G, Jaber S, Barbotte E et al (2006) Impact of systematic evaluation of pain and agitation in an intensive care unit. Crit Care Med 34:1691–1699

    Article  PubMed  Google Scholar 

  7. Chlan LL, Weinert CR, Heiderscheit A et al (2013) Effects of patient-directed music intervention on anxiety and sedative exposure in critically ill patients receiving mechanical ventilatory support: a randomized clinical trial. JAMA 309:2335–2344

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  8. De Kock MF, Lavand’homme PM (2007) The clinical role of NMDA receptor antagonists for the treatment of postoperative pain. Best Pract Res Clin Anaesthesiol 21:85–98

    Article  PubMed  CAS  Google Scholar 

  9. Deutsche Gesellschaft für Anästhesiologie und Intensivmedizin, Deutsche Interdisziplinäre Vereinigung Für Intensiv- Und Notfallmedizin (2015) Analgesie, Sedierung und Delirmanagement in der Intensivmedizin (http://www.awmf.org/leitlinien/detail/ll/001-012.html 001–012)

    Google Scholar 

  10. Drew DJ, Marie StBJ (2011) Pain in critically ill patients with substance use disorder or long-term opioid use for chronic pain. AACN Adv Crit Care 22:238–254 (quiz 255–236)

    Article  PubMed  Google Scholar 

  11. Ehieli E, Yalamuri S, Brudney CS et al (2017) Analgesia in the surgical intensive care unit. Postgrad Med J 93:38–45

    Article  PubMed  Google Scholar 

  12. Elefritz JL, Murphy CV, Papadimos TJ et al (2016) Methadone analgesia in the critically ill. J Crit Care 34:84–88

    Article  PubMed  Google Scholar 

  13. Finnerup NB, Attal N, Haroutounian S et al (2015) Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 14:162–173

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. Fletcher D, Stamer UM, Pogatzki-Zahn E et al (2015) Chronic postsurgical pain in Europe: an observational study. Eur J Anaesthesiol 32:725–734

    Article  PubMed  Google Scholar 

  15. Fredheim OM, Moksnes K, Borchgrevink PC et al (2008) Clinical pharmacology of methadone for pain. Acta Anaesthesiol Scand 52:879–889

    Article  PubMed  CAS  Google Scholar 

  16. Hakkarainen TW, Steele SR, Bastaworous A et al (2015) Nonsteroidal anti-inflammatory drugs and the risk for anastomotic failure: a report from Washington State’s Surgical Care and Outcomes Assessment Program (SCOAP). JAMA Surg 150:223–228

    Article  PubMed  PubMed Central  Google Scholar 

  17. Hamilton TW, Strickland LH, Pandit HG (2016) A meta-analysis on the use of gabapentinoids for the treatment of acute postoperative pain following total knee arthroplasty. J Bone Joint Surg Am 98:1340–1350

    Article  PubMed  Google Scholar 

  18. Herminghaus A, Wachowiak M, Wilhelm W et al (2011) Intravenous administration of lidocaine for perioperative analgesia. Review and recommendations for practical usage. Anaesthesist 60:152–160

    Article  PubMed  CAS  Google Scholar 

  19. Hole J, Hirsch M, Ball E et al (2015) Music as an aid for postoperative recovery in adults: a systematic review and meta-analysis. Lancet 386:1659–1671

    Article  PubMed  Google Scholar 

  20. Johnson MI, Paley CA, Howe TE et al (2015) Transcutaneous electrical nerve stimulation for acute pain. Cochrane Database Syst Rev 6:CD6142. https://doi.org/10.1002/14651858.cd006142.pub3

    Article  Google Scholar 

  21. Lin TF, Yeh YC, Lin FS et al (2009) Effect of combining dexmedetomidine and morphine for intravenous patient-controlled analgesia. Br J Anaesth 102:117–122

    Article  PubMed  CAS  Google Scholar 

  22. Maher DP, Chen L, Mao J (2017) Intravenous ketamine infusions for neuropathic pain management: a promising therapy in need of optimization. Anesth Analg 124:661–674

    Article  PubMed  CAS  Google Scholar 

  23. Martin J, Franck M, Sigel S et al (2007) Changes in sedation management in German intensive care units between 2002 and 2006: a national follow-up survey. Crit Care 11:R124

    Article  PubMed  PubMed Central  Google Scholar 

  24. Meissner W, Coluzzi F, Fletcher D et al (2015) Improving the management of post-operative acute pain: priorities for change. Curr Med Res Opin 31:2131–2143

    Article  PubMed  Google Scholar 

  25. Mo Y, Thomas MC, Antigua AD et al (2017) Continuous Lidocaine infusion as adjunctive analgesia in intensive care unit patients. J Clin Pharmacol 57:830–836

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  26. Moore RA, Derry S, Aldington D et al (2015) Single dose oral analgesics for acute postoperative pain in adults—an overview of Cochrane reviews. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.cd008659.pub3

    Article  PubMed  Google Scholar 

  27. Payen JF, Bosson JL, Chanques G et al (2009) Pain assessment is associated with decreased duration of mechanical ventilation in the intensive care unit: a post Hoc analysis of the DOLOREA study. Anesthesiology 111:1308–1316

    Article  PubMed  Google Scholar 

  28. Puntillo KA, Max A, Timsit JF et al (2014) Determinants of procedural pain intensity in the intensive care unit. The Europain(R) study. Am J Respir Crit Care Med 189:39–47

    PubMed  Google Scholar 

  29. Ramasubbu C, Gupta A (2011) Pharmacological treatment of opioid-induced hyperalgesia: a review of the evidence. J Pain Palliat Care Pharmacother 25:219–230

    Article  PubMed  Google Scholar 

  30. Roeckel LA, Le Coz GM, Gaveriaux-Ruff C et al (2016) Opioid-induced hyperalgesia: cellular and molecular mechanisms. Neuroscience. https://doi.org/10.1016/j.neuroscience.2016.06.029

    Article  PubMed  Google Scholar 

  31. Rothaug J, Weiss T, Meissner W (2012) External validity of pain-linked functional interference: are we measuring what we want to measure? Schmerz 26:396–401

    Article  PubMed  CAS  Google Scholar 

  32. Stueber T, Buessecker L, Leffler A et al (2017) The use of dipyrone in the ICU is associated with acute kidney injury: a retrospective cohort analysis. Eur J Anaesthesiol 34:673–680

    Article  PubMed  CAS  Google Scholar 

  33. Szumita PM, Baroletti SA, Anger KE et al (2007) Sedation and analgesia in the intensive care unit: evaluating the role of dexmedetomidine. Am J Health Syst Pharm 64:37–44

    Article  PubMed  CAS  Google Scholar 

  34. Tobias JD, Leder M (2011) Procedural sedation: a review of sedative agents, monitoring, and management of complications. Saudi J Anaesth 5:395–410

    Article  PubMed  PubMed Central  Google Scholar 

  35. Von Dincklage F (2015) Monitoring of pain, nociception, and analgesia under general anesthesia: relevance, current scientific status, and clinical practice. Anaesthesist 64:758–764

    Article  CAS  Google Scholar 

  36. Wanzuita R, Poli-De-Figueiredo LF, Pfuetzenreiter F et al (2012) Replacement of fentanyl infusion by enteral methadone decreases the weaning time from mechanical ventilation: a randomized controlled trial. Crit Care 16:R49

    Article  PubMed  PubMed Central  Google Scholar 

  37. Weibel S, Jokinen J, Pace NL et al (2016) Efficacy and safety of intravenous lidocaine for postoperative analgesia and recovery after surgery: a systematic review with trial sequential analysis. Br J Anaesth 116:770–783

    Article  PubMed  CAS  Google Scholar 

  38. Whipple JK, Lewis KS, Quebbeman EJ et al (1995) Analysis of pain management in critically ill patients. Pharmacotherapy 15:592–599

    Article  PubMed  CAS  Google Scholar 

  39. Wieseler-Frank J, Maier SF, Watkins LR (2005) Immune-to-brain communication dynamically modulates pain: physiological and pathological consequences. Brain Behav Immun 19:104–111

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Winfried Meißner.

Ethics declarations

Interessenkonflikt

W. Meißner hat Forschungsunterstützung von der EU, dem BMBF, den Firmen Grünenthal und Pfizer sowie Honorare für Beratungs- und Vortragstätigkeiten von den Firmen Mundipharma, Grünenthal, AxelRXPharmaceutics, Menarini und BioQPharma erhalten. K. Rose gibt an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rose, K., Meißner, W. Schmerztherapie bei Intensivpatienten. Anaesthesist 67, 401–408 (2018). https://doi.org/10.1007/s00101-018-0458-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00101-018-0458-x

Schlüsselwörter

Keywords

Navigation